文献速递银屑病与炎症性皮肤病

银屑病患者银屑病关节炎预后预测模型的系统综述

Prognostic prediction models for psoriatic arthritis in psoriasis: A systematic review.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2026-06-18

模型C统计量范围为0.53至0.99,仅3项研究进行了外部验证且判别性能下降,提示模型泛化性存在顾虑。

要点

  • 银屑病患者中银屑病关节炎患病率最高可达22%,早期识别高危患者有助于调整治疗。
  • 纳入490个模型,常用预测因子包括年龄、性别、BMI、HLA-B27、HLA-B08、HLA-C*06、PASI与DLQI。
  • 仅3项研究完成外部验证,验证后判别性能下降,模型可推广性有限。

核心结论

  • 现有银屑病关节炎预后预测模型数量多但外部验证不足,泛化性存疑,未来需构建反映病因的综合模型并加强外部队列验证。

研究设计与样本

  • 全文筛选后纳入15项研究,共包含490个预测模型,数据提取依据CHARMS清单。
  • 采用PROBAST评估偏倚风险,采用TRIPOD-AI评估报告质量。

主要发现

  • 最常用的预测因子为人口学变量(年龄、性别、BMI)、遗传标记(HLA-B27、HLA-B08、HLA-C*06)、临床与患者报告结局(PASI、DLQI)、临床特征及生活方式因素。
  • 9项研究使用机器学习方法(如贝叶斯概率方法、随机森林),其余使用回归和风险评分等传统统计方法。
  • C统计量范围为0.53至0.99;校准度在报告时表现一般;7项研究报告了敏感度与特异度,但阈值与报告方式常不一致。
  • 仅3项研究进行外部验证,验证后判别性能下降。

关键数值与推荐

  • 银屑病患者中银屑病关节炎患病率最高可达22%。
  • C统计量范围为0.53至0.99。
  • 仅3项研究进行了外部验证。

临床怎么用

  • 皮肤科医生可关注现有模型中的候选预测因子(如PASI、DLQI、HLA相关标记)用于风险分层,但模型选择应谨慎考虑其验证状况。

局限性

  • 仅3项研究完成外部验证,模型泛化性证据不足。
  • 校准度报告有限,敏感度与特异度报告的阈值不一致。
  • 预测模型异质性大,难以直接比较或统一推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriatic arthritis is a chronic inflammatory arthropathy that affects up to 22% of individuals with psoriasis. Identifying patients at higher risk of developing this disease presents a window of opportunity for dermatologists to consider treatments that can limit its progression. OBJECTIVES: This study aims to systematically identify and evaluate the predictive performance, risk of bias and reporting quality of prognostic prediction models developed to estimate the risk of psoriatic arthritis in patients with psoriasis. METHOD: A systematic search was conducted across Medline, Embase, Cochrane, Web of Science, pre-print servers and grey literature, with the search completed on 15 October 2025. Data extraction was guided by the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews for Prediction Modelling Studies (CHARMS). The Prediction model Risk of Bias Assessment Tool (PROBAST) and the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD-AI) were used to evaluate risk of bias and reporting, respectively. RESULTS: Fifteen studies were included after full-text screening, comprising of 490 models incorporating a variety of predictors. The most frequently used predictors were demographic variables (age, gender, BMI), genetic markers (HLA-B27, HLA-B08, HLA-C*06), clinician and patient-reported outcomes (PASI, DLQI), clinical features and lifestyle factors. Nine studies used machine learning methods, such as Bayesian probabilistic methods and random forest, whilst the remainder used traditional statistical approaches such as regression and risk scores. The C-statistic ranged from 0.53 to 0.99. Calibration, where reported, was modest and sensitivity and specificity were reported in seven studies, often with inconsistent thresholds and reporting. Only three studies performed external validation, which reduced discriminative performance, raising concerns about generalizability. CONCLUSIONS: Future studies should incorporate a variety of predictors to develop comprehensive models that reflect the aetiology of Psoriatic arthritis whilst ensuring adequate reporting and validation in external cohorts to allow assessment of model performance.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Khoda F, Khan Y, Haw WWY, et al. Prognostic prediction models for psoriatic arthritis in psoriasis: A systematic review. J Eur Acad Dermatol Venereol. 2026. PMID: 42312903. doi:10.1111/jdv.70561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。